Please login to the form below
Taflinar
This page shows the latest Taflinar news and features for those working in and with pharma, biotech and healthcare.
BMS gets two new cancer approvals in Europe
all patents regardless of their BRAF status, potentially making it more useful than BRAF inhibitors such as Roche's Zelboraf (vemurafenib) and Novartis' Taflinar (dabrafenib).
Latest news
-
BMS bags US approval for Opdivo and Yervoy combo
inhibitors such as Roche's Zelboraf (vemurafenib) and GSK's Taflinar (dabrafenib).
-
NICE backs GSK’s Tafinlar for skin cancer
NICE said the information provided by GSK suggested that Taflinar works as well as Zelboraf, which also targets the BRAF V600 mutations.
-
NICE fast-tracks GSK's skin cancer drug Tafinlar
However, just as Roche was forced to discount Zelboraf's price before NICE recommended it, the new Taflinar guidance was only issued on the basis GSK discount its drug's list ... Taflinar was approved in Europe in August 2013, based on phase III results
-
GSK's personalised cancer drug Tafinlar set for European approval
Regulatory advisors recommend the melanoma drug be licensed
More from news
Approximately 2 fully matching, plus 3 partially matching documents found.
Featured jobs
-
Associate Medical Director
-
Highly Competitive
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Director, Market Access / HEOR - North-West
-
Negotiable
-
Account Director
-
Excellent benefits
-
Senior Account Manager
-
Negotiable
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
-
Account Director
-
£48, 000 - £60, 000
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
-
Medical/ Scientific Director
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Senior Systematic Review Analyst - Oxford
-
Negotiable
- Events Manager – Med Comms – Surrey
-
Salary TBC
- Senior Account Executive, London, Medical Communications
-
Excellent package
Subscribe to our email news alerts
- The handover: Pfizer reshapes itself for a new era
- AbbVie sues NHS England over hep C procurement
- GSK among businesses wooed as Brexit reckoning nears
- BioMarin eyes 2019 FDA filing for haemophilia A gene therapy
- The handover: Pfizer reshapes itself for a new era
- Novartis: pipeline will generate 60 filings in three years
- Key considerations for disease- modifying Parkinson’s disease trials
- Artificial Intelligence In Healthcare Market to Witness Exponential Growth by 2027
- Breathing Exercise Devices Market Intelligence Report Offers Growth Prospects
- Micro-CT Scanners Market 10-Year Market Forecast and Trends Analysis Research Report
- Next Generation Infusion Pump Market Healthy Pace throughout the Forecast during 2017 – 2027
- Wireless Brain Sensors Market Intelligence Report Offers Growth Prospects
PMHub
emotive.
emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...
Latest intelligence
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
- Quality in Care Diabetes 2018: the best in innovative diabetes care
- Awards highlight new evidence-based approaches to improving care...
Quick links
Infographics
